Immunogen, (IMGN) Up 10.57% for August 4

Equities Staff  |

Immunogen, Inc. (NASDAQ:IMGN) shares gained 10.57% today on 2,658,395 shares - while the stock has a 30 day average of 2,914,255 shares traded.

With today’s closing at $5.44 the company has a 50 day moving average of $4.8.

The company expects its next earnings on 2022-10-28.

Immunogen, is down 33.69% so far this year.

For technical charts, analysis, and more on Immunogen, visit the company profile.

About Immunogen, Inc.

ImmunoGen is developing the next generation of antibody-drug conjugates to improve outcomes for cancer patients. By generating targeted therapies with enhanced anti-tumor activity and favorable tolerability profiles, the company aims to disrupt the progression of cancer and offer its patients more good days.

To get more information on Immunogen, Inc. and to follow the company's latest updates, you can visit the company's profile page here: Immunogen, Inc.'s Profile. For more news on the financial markets be sure to visit Equities News. Also, don't forget to sign-up for the Daily Fix to receive the best stories to your inbox 5 days a week.

Sources: Symbol info widget is provided by TradingView based on 15-minute-delayed prices. All other article data is provided by IEX Cloud on 15-minute delayed prices or EOD company info.

Stock price data is provided by IEX Cloud on a 15-minute delayed basis. Chart price data is provided by TradingView on a 15-minute delayed basis.

DISCLOSURE: The views and opinions expressed in this article are those of the authors, and do not represent the views of Readers should not consider statements made by the author as formal recommendations and should consult their financial advisor before making any investment decisions. To read our full disclosure, please go to:

Trending Articles

The Strong Dollar Is a Problem for Stocks
3 Ways Finance Teams Can Navigate Inflation Through Automation

Market Movers

Sponsored Financial Content